Author:
de Ataíde Góes Ana Carolina,Skaf Heni Debs,Testa Laura
Publisher
Springer International Publishing
Reference69 articles.
1. Croshaw R, Shapiro-Wright H, Svensson E, Erb K, Julian T. Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients. Ann Surg Oncol. 2011;18(11):3160–3. https://doi.org/10.1245/s10434-011-1919-5.
2. Keune JD, Jeffe DB, Schootman M, Hoffman A, Gillanders WE, Aft RL. Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer. Am J Surg. 2010;199(4):477–84. https://doi.org/10.1016/j.amjsurg.2009.03.012.
3. Lehman C. ACR practice parameter for the performance of contrast-enhanced magnetic resonance imaging (MRI) of the breast. Am Coll Radiol. 2013. Available at: https://www.acr.org/-/media/ACR/Files/Practice-Parameters/mr-contrast-breast.pdf
4. Mann RM, Kuhl CK, Kinkel K, Boetes C. Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol. 2008;18(7):1307–18. https://doi.org/10.1007/s00330-008-0863-7.
5. Herrada J, Iyer RB, Atkinson EN, Sneige N, Buzdar AU, Hortobagyi GN. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res. 1997;3(9):1565–9.